Cor Vasa 2012, 54(5-6):319-321

Zpráva z kongresu European Heart Failure 2012

Doc. MUDr. Filip Málek, Ph.D.
Kardiovaskulární centrum Nemocnice Na Homolce

Published: May 1, 2012  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Málek F. Zpráva z kongresu European Heart Failure 2012. Cor Vasa. 2012;54(5-6):319-321.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J 2012 May 19. doi:10.1093/eurheartj/ehs104.
    2. ©pinar J, Vítovec J, Hradec J, Málek I, et al. Doporučený postup České kardiologické společnosti pro diagnostiku a léčbu chronického srdečního selhání, 2011. Cor Vasa 2012;54:161-82. Go to original source...
    3. Swedberg K, Komajda M, Bohm M, et al. Ivabradin and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled trial. Lancet 2010;376:875-85. Go to original source... Go to PubMed...
    4. Granger BG, Alexander JH, McMurray JJ, et al., for ARISTOTLE Investigators. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med 2011;365:981-92. Go to original source... Go to PubMed...
    5. Ostojic M, Behfar A, Henry S, et al. C-CURE Multicenter Trial: Lineage Specified Bone Marrow Derived Cardiopoietic Mesenchymal Stem Cells for Treatment of Ischemic Cardiomyopathy. J Am Coll Cardiol 2011;57:E200. Go to original source...
    6. Liu LC, Voors AA, van Veldhuisen DJ, et al. Vitamin D status and outcomes in heart failure patients. Eur J Heart Fail 2011;13:619-25. Go to original source... Go to PubMed...
    7. Zannad F, McMurray JJ, Krum H, et al.; for EMPHASIS-HF Investigators. Eplerenone in patients with systolic heart failure nad mild symptoms. N Engl J Med 2011;364:11-21. Go to original source... Go to PubMed...
    8. O'Connor CM, Hasselblad V, Mehta RH. Triage after hospitalization with advanced heart failure: the ESCAPE (Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness) risk model and discharge score. A AM Coll Cardiol 2010;55:872-8. Go to original source... Go to PubMed...
    9. Jacobson AF, Senior R, Cerqueira M, et al. Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) study. J Am Coll Cardiol 2010;55:2212-21. Go to original source... Go to PubMed...
    10. The Digitalis Investigation Group. The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med 1997;336:525-33. Go to original source... Go to PubMed...
    11. Böhm M, Borer J, Ford A, et al. Heart rate at baseline influences the effect of ivabradine on cardiovascular outcomes in chronic heart failure: analysis from the SHIFT study. Clin Res Cardiol 2012. DOI 10.1007/s00392-012-0467-8. Go to original source...

    Return to the content


    Cor et Vasa

    You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

    I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.


    No
    Yes